| 1 | A bill to be entitled |
| 2 | An act relating to compounded medicinal drugs; amending s. |
| 3 | 465.003, F.S.; revising a definition; creating s. 465.055, |
| 4 | F.S.; authorizing certain pharmacists and pharmacies to |
| 5 | compound medicinal drugs and deliver such drugs to certain |
| 6 | prescribers for the in-office use of the prescriber; |
| 7 | authorizing certain pharmacists to dispense compounded |
| 8 | medicinal drugs to certain prescribers; providing minimum |
| 9 | standards to govern the dispensing of such compounded |
| 10 | medicinal drugs; providing an effective date. |
| 11 |
|
| 12 | Be It Enacted by the Legislature of the State of Florida: |
| 13 |
|
| 14 | Section 1. Subsection (6) of section 465.003, Florida |
| 15 | Statutes, is amended to read: |
| 16 | 465.003 Definitions.--As used in this chapter, the term: |
| 17 | (6) "Dispense" means the transfer of possession of one or |
| 18 | more doses of a medicinal drug by a pharmacist to the ultimate |
| 19 | consumer or her or his agent. As an element of dispensing, the |
| 20 | pharmacist shall, prior to the actual physical transfer, |
| 21 | interpret and assess the prescription order for potential |
| 22 | adverse reactions, interactions, and dosage regimen she or he |
| 23 | deems appropriate in the exercise of her or his professional |
| 24 | judgment, and the pharmacist shall certify that the medicinal |
| 25 | drug called for by the prescription is ready for transfer. The |
| 26 | pharmacist shall also provide counseling on proper drug usage, |
| 27 | either orally or in writing, if in the exercise of her or his |
| 28 | professional judgment counseling is necessary. The actual sales |
| 29 | transaction and delivery of such drug shall not be considered |
| 30 | dispensing. The administration shall not be considered |
| 31 | dispensing. For purposes of compounded medicinal drugs only, the |
| 32 | term "ultimate consumer or her or his agent" shall specifically |
| 33 | include an authorized prescriber, or his or her agent, using |
| 34 | such compounded medicinal drugs for in-office use pursuant to s. |
| 35 | 465.055. |
| 36 | Section 2. Section 465.055, Florida Statutes, is created |
| 37 | to read: |
| 38 | 465.055 Compounding for in-office use.-- |
| 39 | (1) Notwithstanding any other provision of law, a |
| 40 | Florida-licensed pharmacist or a Florida-licensed pharmacy may |
| 41 | compound a reasonable amount of a medicinal drug and deliver |
| 42 | such drug to an authorized prescriber for such prescriber's |
| 43 | administration or provision of the compounded medicinal drug to |
| 44 | a patient by the prescriber or his or her agent, in the |
| 45 | prescriber's primary practice office or any other state-licensed |
| 46 | health care facility where the prescriber or his or her agent is |
| 47 | authorized by law to prescribe or otherwise treat a patient with |
| 48 | any prescription drug therapy. |
| 49 | (2) A Florida-licensed pharmacist may dispense a |
| 50 | compounded medicinal drug for in-office use to a prescriber |
| 51 | authorized by law to prescribe, administer, or otherwise treat a |
| 52 | patient with such compounded medicinal drug. |
| 53 | (3) The amount of a compounded medicinal drug dispensed |
| 54 | under this section shall not exceed the amount that either the |
| 55 | prescriber or the pharmacist reasonably anticipates, based upon |
| 56 | the exercise of each of such prescriber's or pharmacist's |
| 57 | independent professional judgment, may be used by the prescriber |
| 58 | for in-office use prior to the expiration date of all such |
| 59 | compounded medicinal drug. |
| 60 | (4) The substantive quantity of a compounded medicinal |
| 61 | drug dispensed under this section shall be reasonably |
| 62 | calculated, based upon the pharmacist's understanding of the |
| 63 | prescriber's intended use of such compounded drug given the |
| 64 | nature of such prescriber's professional practice and the nature |
| 65 | of the patient profiles served by such practice. |
| 66 | (5) The amount of a compounded medicinal drug dispensed |
| 67 | under this section by the pharmacist shall be in compliance with |
| 68 | the pharmaceutical standards for identity, strength, quality, |
| 69 | and purity of the compounded drug that are consistent with the |
| 70 | United States Pharmacopoeia guidelines and accreditation |
| 71 | practices. |
| 72 | (6) A compounded medicinal drug provided by a pharmacist |
| 73 | under this section shall be, under the independent professional |
| 74 | judgment of the prescriber, medically necessary for a particular |
| 75 | patient at the time of its delivery by the prescriber to the |
| 76 | patient. |
| 77 | (7) A compounded medicinal drug, once dispensed under this |
| 78 | section by the pharmacist, to the medical practitioner for in- |
| 79 | office use, shall not be further subdivided for the purpose of |
| 80 | retail distribution beyond what is otherwise deemed usual and |
| 81 | customary. |
| 82 | Section 3. This act shall take effect July 1, 2007. |